Last reviewed · How we verify

NCT03365674

Vibration for Pain Reduction During Trigger Point Injection

Completed NA Last updated 22 February 2019
What this trial tests

NA trial testing Vibration in Myofascial Pain Syndromes in 60 participants. Completed in 30 April 2018.

Timeline
30 September 2017
Primary endpoint
30 March 2018
30 April 2018

Quick facts

Lead sponsorThe Catholic University of Korea
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment60
Start date30 September 2017
Primary completion30 March 2018
Estimated completion30 April 2018
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

The Catholic University of Korea

Who can join

20 and older, any sex, with Myofascial Pain Syndromes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the effects of vibration anesthesia for reducing pain induced by trigger point injection of gastrocnemius. Sixty patients were randomized into the vibration or placebo group. In vibration groups, vibrator head was applied (100Hz) on the popliteal fossa, during the trigger point injection. In placebo group, same vibrator head was applied with switch-off sate. Then, a visual analog scale to evaluate the pain of trigger point injection and a five-point Likert scale for patients satisfaction were compared between the two groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Vibration

Trials testing the same drug.

Other recruiting trials for Myofascial Pain Syndromes

Currently open trials in the same condition.

Other The Catholic University of Korea trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03365674.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing